 For some of the tools that we were investing in that were wanted as a matter of urgency, it takes years to build. It takes years to build the infrastructure and the technology. It takes years to build the partnerships that you need for the entire value chain for producing therapeutics, diagnostics, as well as vaccines. So here we were coming in, you know, within this situation and trying to do this urgently when we might have done better perhaps if we had invested earlier. What is very important for me is that we have a funding program system on a supranational level so that the different national states involved, for example in the African Union or in the European Union, get into a kind of competition in funding, research, and higher education. And that is only be possible if we really negotiate these funding programs on a supranational level. So sustainable financing architecture for research and development and of course an active participation of the private sector. This is very important. This is a synergy that will give us a win-win effect and impact in the Africa we want.